Three Possible Pathophysiologic Mechanisms for the Formation of Autism Spectrum Disorder
DOI:
https://doi.org/10.54097/hset.v36i.6182Keywords:
Autism Spectrum Disorder, Neuron Signal Transportation, Glutamine Receptor-relate Proteins, Neuroimmunology System.Abstract
Autism spectrum disorder (ASD), is a childhood neurodevelopment psychiatric disease formed by strong genetic factors. Normally, communication and social interaction deficits, and repetitive stereotype behaviors are the most common symptoms caused by ASD. Until now, although several treatments, such as depressive inhibitors, antipsychotic drugs, and psychotherapy, have been used to fight against ASD, however, the mechanism of the formation of ASD is still unclear. Previously, since the channels and regulatory factors of ASD are partly discovered, these treatments can only alleviate some of the ASD symptoms, but do not eradicate the psychiatric disease due to the consideration of drug side effects. Therefore, it is necessary to discover new treatment methods by making thorough inquiries on different pathophysiologic mechanism-passageways that contribute to ASD. Many factors might determine the formation of ASD, but only three types of theories, focusing on neuron signal transportation, glutamine receptors, and neuron immune system, are considered to be the most promising ASD-mechanism directions. Through collecting and analyzing relevant cell functions and structures, this article mainly explains the causes of ASD core or partial symptoms by pointing out three promising pathophysiologic ASD mechanisms at the cellular level, and analyses the reasons for the changes in the functions and structures of some related cells at the molecular level.
Downloads
References
Yenkoyan, K., A. Grigoryan, K. Fereshetyan, et al. Advances in understanding the pathophysiology of autism spectrum disorders [J]. Behav Brain Res, 2017, 331: 92 - 101.
Courchesne, E., K. Pierce, C.M. Schumann, et al. Mapping early brain development in autism [J]. Neuron, 2007, 56 (2): 399 - 413.
Opris, I. and M.F. Casanova. Prefrontal cortical minicolumn: from executive control to disrupted cognitive processing [J]. Brain, 2014, 137 (Pt 7): 1863 - 75.
Jamain, S., H. Quach, C. Betancur, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism [J]. Nat Genet, 2003, 34 (1): 27 - 9.
Wang, Z., Y. Hong, L. Zou, et al. Reelin gene variants and risk of autism spectrum disorders: an integrated meta-analysis[J]. Am J Med Genet B Neuropsychiatr Genet, 2014, 165B (2):192 - 200.
Seyfarth, R.M. and D.L. Cheney. Affiliation, empathy, and the origins of theory of mind [J]. Proc Natl Acad Sci U S A, 2013,110 Suppl 2: 10349 - 56.
Helt, M.S., I. M. Eigsti, P. J. Snyder, et al. Contagious yawning in autistic and typical development [J]. Child development, 2010 ,81 (5): 1620 - 1631.
Nisar, S., A.A. Bhat, T. Masoodi, et al. Genetics of glutamate and its receptors in autism spectrum disorder[J]. Mol Psychiatry, 2022,27(5):2380-2392.
Darnell, J.C., S.J. Van Driesche, C. Zhang, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism [J]. Cell, 2011, 146 (2): 247 - 61.
Menard, C. and R. Quirion. Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain [J]. Front Pharmacol, 2012, 3: 182.
Radyushkin, K., K. Hammerschmidt, S. Boretius, et al. Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit [J]. Genes Brain Behav, 2009, 8 (4): 416 - 25.
Jaramillo, T.C., S. Liu, A. Pettersen, et al. Autism-related neuroligin-3 mutation alters social behavior and spatial learning [J]. Autism Res, 2014, 7 (2): 264 - 72.
Onore, C., M. Careaga, and P. Ashwood. The role of immune dysfunction in the pathophysiology of autism [J]. Brain Behav Immun, 2012, 26 (3): 383 - 92.
Bessis, A., C. Bechade, D. Bernard, et al. Microglial control of neuronal death and synaptic properties [J]. Glia, 2007, 55 (3): 233 - 8.
Harden, L.M., I. du Plessis, S. Poole, et al. Interleukin (IL)-6 and IL-1 beta act synergistically within the brain to induce sickness behavior and fever in rats[J]. Brain Behav Immun, 2008, 22 (6): 838 - 49.
Zalcman, S.S. Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists [J]. Brain research, 2002, 944 (1-2): 157 - 164.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







